Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody Titers against Mpox Virus after Vaccination.
Kottkamp AC, Samanovic MI, Duerr R, Oom AL, Belli HM, Zucker JR, Rosen JB, Mulligan MJ; NYC OSMI Study Group. Kottkamp AC, et al. Among authors: mulligan mj. N Engl J Med. 2023 Dec 14;389(24):2299-2301. doi: 10.1056/NEJMc2306239. N Engl J Med. 2023. PMID: 38091537 Free PMC article. No abstract available.
Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
Munoz FM, Beigi R, Posavad CM, Kelly C, Badell ML, Bunge K, Mulligan MJ, Parameswaran L, Richardson BA, Olsen-Chen C, Novak RM, Brady RC, DeFranco E, Gerber JS, Shriver M, Suthar MS, Coler R, Berube BJ, Kim SH, Piper JM, Miedema J, Pasetti M, Neuzil KM, Cardemil CV; DMID Study Group. Munoz FM, et al. Among authors: mulligan mj. Pediatr Infect Dis J. 2024 Nov 1;43(11):1065-1073. doi: 10.1097/INF.0000000000004510. Epub 2024 Aug 13. Pediatr Infect Dis J. 2024. PMID: 39774938
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans.
Cortese M, Hagan T, Rouphael N, Wu SY, Xie X, Kazmin D, Wimmers F, Gupta S, van der Most R, Coccia M, Aranuchalam PS, Nakaya HI, Wang Y, Coyle E, Horiuchi S, Wu H, Bower M, Mehta A, Gunthel C, Bosinger SE, Kotliarov Y, Cheung F, Schwartzberg PL, Germain RN, Tsang J, Li S, Albrecht R, Ueno H, Subramaniam S, Mulligan MJ, Khurana S, Golding H, Pulendran B. Cortese M, et al. Among authors: mulligan mj. Nat Immunol. 2025 Jan;26(1):116-130. doi: 10.1038/s41590-024-02036-z. Epub 2025 Jan 2. Nat Immunol. 2025. PMID: 39747435
Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adults.
Phadke VK, Gromer DJ, Rebolledo PA, Graciaa DS, Wiley Z, Sherman AC, Scherer EM, Leary M, Girmay T, McCullough MP, Min JY, Capone S, Sommella A, Vitelli A, Retallick J, Seetahal J, Koller M, Tsong R, Neill-Gubitz H, Mulligan MJ, Rouphael NG. Phadke VK, et al. Among authors: mulligan mj. Vaccine. 2024 Dec 2;42(26):126441. doi: 10.1016/j.vaccine.2024.126441. Epub 2024 Oct 16. Vaccine. 2024. PMID: 39418686 Clinical Trial.
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial.
Davey RT Jr, Collins GL, Rouphael N, Poliquin G, McConnell R, Grubbs G, Moir SL, Langley JM, Teitelbaum M, Hewlett AL, McLellan SLF, Bhadelia N, Raabe VN, Mulligan MJ, Maljkovic Berry I, Dighero-Kemp B, Kurtz JR, Hensley LE, Dozier NCE, Marron LCB, DuChene A, Kuhn JH, Brown SK, Khurana S, Lane HC, Neaton JD. Davey RT Jr, et al. Among authors: mulligan mj. Lancet Microbe. 2024 Nov;5(11):100923. doi: 10.1016/S2666-5247(24)00163-0. Epub 2024 Oct 4. Lancet Microbe. 2024. PMID: 39374605 Free article. Clinical Trial.
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Follmann D, Gilbert PB; Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team. Fong Y, et al. Clin Infect Dis. 2024 Sep 26:ciae465. doi: 10.1093/cid/ciae465. Online ahead of print. Clin Infect Dis. 2024. PMID: 39325506
SARS-CoV-2 inflammation durably imprints memory CD4 T cells.
Gray-Gaillard SL, Solis SM, Chen HM, Monteiro C, Ciabattoni G, Samanovic MI, Cornelius AR, Williams T, Geesey E, Rodriguez M, Ortigoza MB, Ivanova EN, Koralov SB, Mulligan MJ, Herati RS. Gray-Gaillard SL, et al. Among authors: mulligan mj. Sci Immunol. 2024 Jun 21;9(96):eadj8526. doi: 10.1126/sciimmunol.adj8526. Epub 2024 Jun 21. Sci Immunol. 2024. PMID: 38905326
Emergence and dissemination of SARS-CoV-2 XBB.1.5 in New York.
Gámbaro F, Duerr R, Dimartino D, Marier C, Iturrate E, Mulligan MJ, Heguy A, Dellicour S. Gámbaro F, et al. Among authors: mulligan mj. Virus Evol. 2024 May 7;10(1):veae035. doi: 10.1093/ve/veae035. eCollection 2024. Virus Evol. 2024. PMID: 38774310 Free PMC article.
238 results